Skip to main content

Circumvention of natural killer cell and T-cell mediated allogeneic target killing with tacrolimus (FK506) in small bowel transplantation related graft-vs-host disease

  • Conference paper
Transplant International

Abstract

The role of simultaneous donor-specific transfusion of unprocessed cellular bone marrow (BM) together with solid organ transplantation, a postulated concept to achieve long-term graft acceptance, was investigated in an experimental setting of semiallogeneic transplantation of parental small bowel (SBTx) to F 1 hybrids. The established graft-vs-host (GvH) model revealed that simultaneous transfer of SB/BM substantially enhanced GvH-mediated immune responses in recipient target organs, e.g. skin, gut, and liver. In comparison to isolated SBTx, animal survival decreased from 16.1(± 0.9) to 10.1(± 0.8) days after additional BM transfusion, P < 0.001. Severe tissue injury of GvH-susceptible target organs in the setting of simultaneous SB and BMTx was associated with significant changes in recruitment and tissue distribution of NKR-P1+ cells during the GvH-related proliferative immune response. Tacrolimus effectively suppressed these initial events and prevented recipient animals from clinically and histologically observed damage caused by GvH disease.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Similar content being viewed by others

References

  1. Billingham RE, Brent L, Medawar P (1956) Quantitative studies on tissue transplantation immunity. III. Actively acquired tolerance. Philos Trans R Soc London SerB 239: 357–412

    Google Scholar 

  2. Slavin S, Strober S, Fuks Z, Kaplan HS (1977) Induction of specific tissue transplantation tolerance using fractionated total lymphoid irradiation in adult mice. Long-term survival of allogeneic bone marrow and skin grafts. J Exp Med 146: 34–48

    Google Scholar 

  3. Starzl TE, Demetris AJ, Trucco M, Ramos H, Zeevi A, Rudert WA, Kocova M, Ricordi C, Ildstad S, Murase N (1992) Systemic chimerism in human female recipients of male livers. Lancet 340: 876–877

    Article  PubMed  CAS  Google Scholar 

  4. Starzl TE, Demetris AJ, Trucco M, Zeevi A, Ramos H, Terasaki P, Rudert WA, Kocova M, Ricordi C, Ildstad S, Murase N (1993) Chimerism and donor-specific nonreactivity 27 to 29 years after kidney allotransplantation. Transplantation 55: 1272–1277

    Article  PubMed  CAS  Google Scholar 

  5. Starzl TE, Demetris AJ, Trucco M, Murase N, Ricordi C, Ildstad S, Ramos H, Todo S, Tzakis A, Fung JJ, Nalesnik M, Zeevi A, Rudert WA, Kocova M Cell migration and chimerism after whole organ transplantation: the basis of graft acceptance. Hepatology 17: 1127–1152

    Google Scholar 

  6. Lechler RI, Batchelor JR (1982) Restoration of immunogenicity to passenger cell-depleted kidney allografts by the addition of donor-strain dendritic cells. J Exp Med 155: 31–41

    Article  PubMed  CAS  Google Scholar 

  7. Bushell A, Pearson TC, Morris PJ, 13. Wood KJ (1995) Donor-recipient microchimerism is not required for tolerance induction following recipient pretreatment with donor-specific transfusion and anti-CD 4 antibody: Evidence of a clear role for short-term antigen persistence. Transplantation 59: 1367 1371 14.

    Google Scholar 

  8. Schlitt HJ, Hundrieser J, Ringe B, Pichlmayr R (1994) Donor-type microchimerism associated with graft rejection eight years after liver transplantation. N Eng J Med 330: 646–647

    Article  CAS  Google Scholar 

  9. Naper C, Vaage JT, Lambracht D, Lovik G, Butcher GW, Wonigeit K, Rolstad B (1995) Alloreactive natural killer 15. cells in the rat: complex genetics of major histocompatibility complex control. Eur J Immunol 25: 1249–1256

    Article  PubMed  CAS  Google Scholar 

  10. Rolstad B, Fossum S, Bazin H, Kimber I, Marshall J, Sparshott SM, Ford WL 16. (1985) The rapid rejection of allogeneic lymphocytes by a non-adaptive, cell-mediated mechanism ( NK activity ). Immunology 54: 127-138

    Google Scholar 

  11. Biassoni R, Ferrini S, Prigione I, Pelak VS, Sekaly RP, Long EO (1991) Acti- 17. vated CD 3 CD 16 + natural killer cells express a subset of the lymphokine genes induced in activated a (3” and y S’ 18. T cells. Scand J Immunol 33: 247-252

    Google Scholar 

  12. Bankhurst AD, Imir T (1989) The mechanisms involved in the activation 19. of human natural killer cells by staphylococcal enterotoxin (I. Cell Immunol 122: 108–122

    Article  PubMed  Google Scholar 

  13. Manetti R, Parronchi P, Giudizi MG, Piccinni MP, Maggi E, Trinchieri G, Romagnani S (1993) Natural killer cell stimulatory factor (interleukin 12[IL12]) induces T helper type 1 (TH I)-specific immune responses and inhibits the development of IL-4 producing cells. J Exp Med 177: 1199–1204

    Article  PubMed  CAS  Google Scholar 

  14. Fändrich F, Waaga AM, Schröder.1, Schweizer E, Schroeder P (1994) Tissue dependent alteration of the MHC-I and -II expression after the use of deoxyspergualin for suppression of the graftversus-host disease in small bowel transplantation. Transplant Proc 26: 1592–1593

    PubMed  Google Scholar 

  15. Fossum S, Rolstad B (1986) The roles of interdigitating cells (IDC) and natural killer ( NK) cells in the rapid rejection of allogeneic lymphocytes. Eur J Immunol 16: 440-450

    Google Scholar 

  16. Rolstad B, Herberman RB, Reynolds CW (1986) Natural killer cell activity in the rat. V. The circulation patterns and tissue localization of peripheral blood large granular lymphocytes ( LGL ). J Immunol 136: 2800-2809

    Google Scholar 

  17. Coutinho A (1989) Beyond clonal selection and network. Immunol Rev 110: 63–87

    Article  PubMed  CAS  Google Scholar 

  18. Cohen IR (1992) The cognitive paradigm and the immunological homunculus. Immunol Today 13: 490–492

    Article  PubMed  CAS  Google Scholar 

  19. Hansson M, Petersson M, Koo GC, Wigzell H, Kiessling R (1988) In vivo function of natural killer cells as regulators of myeloid precursor cells in the spleen. Eur J Immunol 18: 485–488

    Article  PubMed  CAS  Google Scholar 

  20. Murphy WJ, Kumar V, Bennett M (1987) Acute rejection of murine bone marrow allografts by natural killer cells and T cells. J Exp Med 166: 1499–1509

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1996 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Fändrich, F., Jahnke, T., Peters, J., Exner, B., Papachrysanthou, A., Zavazava, N. (1996). Circumvention of natural killer cell and T-cell mediated allogeneic target killing with tacrolimus (FK506) in small bowel transplantation related graft-vs-host disease. In: Mühlbacher, F., et al. Transplant International . Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-00818-8_67

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-00818-8_67

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-61024-3

  • Online ISBN: 978-3-662-00818-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics